The engagement of ADO and the ADO 2A receptors (A2AR, an immune checkpoint) on various immune cell surfaces hampers the immune reaction toward tumor cells, further exacerbating tumor immunosuppression11–13. Here, ADORA2A is linked to neoplasm.